...
首页> 外文期刊>Heart >Serological and molecular evidence of enterovirus infection in patients with end-stage dilated cardiomyopathy
【24h】

Serological and molecular evidence of enterovirus infection in patients with end-stage dilated cardiomyopathy

机译:终末期扩张型心肌病患者肠道病毒感染的血清学和分子证据

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Objective—To study the relative diagnostic value of enterovirus-specific molecular biological and serological assays in patients with end-stage dilated cardiomyopathy, and to investigate the possible role of other cardiotropic viruses in dilated cardiomyopathy. Design—Analysis of recipient myocardial tissue and serum from patients with dilated cardiomyopathy and controls undergoing cardiac transplantation for end-stage cardiac disease. Setting—University virology department and transplantation unit. Methods—Reverse transcriptase-poly-merase chain reaction and nucleotide sequence analysis of myocardial RNA and DNA; enterovirus-specific in situ hybridisation; enterovirus-specific immunoglob-ulin M detection. Results—Enterovirus RNA was detected in myocardial tissue from only a small proportion of (five of 75) hearts. However, although enterovirus-specific immuno-globulin M responses were detected in 22 (28%) of 39 controls patients, a significantly higher prevalence was observed among patients with dilated cardiomyopathy (22 (56%) of 39 patients; P < 0.005). All enteroviruses detected in myocardium showed greatest nucleotide sequence homology with coxsackievirus type B3. Detection of enterovirus RNA in myocardium by the polymerase chain reaction and by in situ hybridisation gave comparable results. Other potentially cardiotropic virus genomes, including human cytomegalovirus, influenzaviruses, and coronaviruses were not detected in myocardium. Conclusion—This study found that enterovirus-specific immunoglobulin M responses provided the strongest evidence of enterovirus involvement in patients with end-stage dilated cardiomyopathy. However, the high background prevalence of these responses limits their diagnostic value. The finding that enteroviruses detected in myocardium were coxsackievirus type B3 accords with recent findings in patients with acute myocarditis, and indicates that this serotype is the major cardiotropic human enterovirus.
机译:目的—研究肠道病毒特异性分子生物学和血清学检测在终末期扩张型心肌病患者中的相对诊断价值,并探讨其他心肌病病毒在扩张型心肌病中的可能作用。设计-分析扩张型心肌病患者和接受心脏移植的终末期心脏病患者的对照者的心肌组织和血清。设置-大学病毒学系和移植科。方法—心肌RNA和DNA的逆转录酶-聚合酶链反应和核苷酸序列分析;肠道病毒特异性原位杂交;肠病毒特异性免疫球蛋白M检测。结果-在心肌组织中仅从一小部分(75个心脏)中检测到肠病毒RNA。然而,尽管在39例对照患者中有22例(28%)检测到了肠病毒特异性免疫球蛋白M反应,但在扩张型心肌病患者中观察到了更高的患病率(39例中22例(56%); P <0.005)。在心肌中检测到的所有肠病毒均显示与B3型柯萨奇病毒最大的核苷酸序列同源性。通过聚合酶链反应和原位杂交检测心肌中的肠病毒RNA可得到相当的结果。在心肌中未检测到其他潜在的促心脏病毒基因组,包括人巨细胞病毒,流感病毒和冠状病毒。结论-这项研究发现,对于晚期扩张型心肌病患者,肠道病毒特异性免疫球蛋白M反应提供了肠道病毒参与的最有力证据。但是,这些反应的高背景患病率限制了它们的诊断价值。在心肌中检测到的肠病毒是柯萨奇病毒B3型,这一发现与急性心肌炎患者的最新发现相符,并表明该血清型是主要的向心性人类肠道病毒。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号